Special Reports

The authors present a clinically focused introduction to treatment principles for adolescent substance abuse disorders and reviews evidence-based approaches.

The Chair of a Special Report on substance abuse disorders describes the highlights of 6 articles in the series.

In psychiatry, hot debates abound if you just look around-and if this Special Report collection is any indication, the result is a balance of opinion and civility made richer by virtue of opposing views.

An overview of the DSM diagnostic system, the medicalization of normal variants of human behavior, and physician-assisted suicide.

Here's why psychiatrists and other mental health professionals need to understand the relationship between cannabis and mental disorders.

This article speaks to the care with which ADHD must be diagnosed and managed to reduce the significant negative impact of the disorder on the individual, family, and society.

Physician-assisted suicide is now legal in several states. But none of the state statues mandates a mental health evaluation by a psychiatrist or psychologist before the writing of a lethal prescription by an attending physician.

Strong evidence supports sound arguments on each side of 3 debates covered here-so get in there and fight nice.

This special report on controversies in psychiatry examines the pros and cons of assisted outpatient treatment and also antidepressant use in pregnancy.

The authors examine legal and ethical challenges for the psychiatrist when a defendant who is incompetent to stand trial declines to take prescribed psychotropic medication.

This article summarizes the risks of untreated psychiatric illness during pregnancy as well as the risks and benefits of antidepressant use.

When clinicians work without ready access to a security team or environmental safety protocols, early recognition is crucial to preventing or avoiding those rare occasions when behavior problems escalate.

An update on emerging trends in psychosomatic medicine to help clinicians address mental health stressors in psychiatric and medical settings.

The authors shed light on a disorder that is difficult to diagnose and manage, and offer insights on how to develop an appropriate treatment plan.

Renewed interest and emerging systematic data have highlighted the frequency and pattern of catatonic presentations in psychiatric and medical settings, including in critical illness.

Psychiatrists need to understand the patient’s cancer diagnosis, staging, treatments and their adverse effects, and prognosis to appreciate the challenges the patient is coping with throughout treatment as well as survivorship or end-of-life.

Strategies to reduce aggression in psychiatric treatment settings.

Here's an overview of motivation for assaults by chronically aggressive inpatients and steps to de-escalate.

The authors review the association between depression and violence, and the role that anger and emotional dysregulation play.

There is no predictive tool that is likely to have validity for rare outcomes such as terrorist attacks. More here.

Here's compelling reason for judicious use of restraint and seclusion, and a review of various alternative approaches.

How could this have happened? What could you do to keep yourself and your team safe from another code white?

What effects do illness and treatment have on cognition? Here's a deep dive.

Functional mood stability can be attained with lithium therapy, but guidelines on how to get there have become increasingly sophisticated.

Personal enhancements (eg, cosmetic surgery) have gained societal acceptance, but cognitive enhancement poses significant ethical, philosophical, and sociopolitical issues.

Targeted mineral supplementation has the potential to augment treatment response and yield improvement in clinical symptoms.

Integrative psychiatry helps us push deeper into the testing of metabolic, gut, and brain features, which seems more fitting, given our role as physicians.

These methods facilitate deep rest, help reset circadian rhythm, and release endogenous opioids and cannabinoids that help reduce anxiety and enhance a sense of well-being for people with PTSD.